Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LILLY'S SALE OF IVAC TO RIVER ACQUISITION CORP.

This article was originally published in The Gray Sheet

Executive Summary

LILLY'S SALE OF IVAC TO RIVER ACQUISITION CORP. is the second divestiture under Lilly's plan to separate its device units from its core pharmaceutical business; the definitive agreement was announced Nov. 29. As with the July sale of Lilly's Physio-Control unit to Bain Capital, an investment firm is playing a significant role in the purchase of IVAC. River Acquisition Corp. was recently formed by DLJ Merchant Banking Partners and River Medical, Inc. for the purchase.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003160

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel